Disclosure 0001493152-26-039048-1

SEC FORM 4

—

Dermata Therapeutics, Inc. (DRMA)

Acquisition (code A) of 170,068 shares; price not stated (see filing).

Reporting Person PROEHL GERALD T · Officer Title PRESIDENT, CHAIRMAN, CEO · Transaction Code A

Traded Aug 16, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001493152-26-039048 · filed 2026-08-18 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Dermata Therapeutics, Inc. (DRMA)." Disclosed 2026-08-18. https://desqlong.com/cards/0001493152-26-039048-1 (retrieved 2026-09-26).